Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission

Lee Farrand; Sanguine Byun; Ji Young Kim; Akechai Im-Aram; Jihoon Lee; Semi Lim; Ki Won Lee; Jeong Yong Suh; Hyong Joo Lee; Benjamin K. Tsang

doi:10.1074/jbc.M113.487686

Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission

Lee Farrand, Sanguine Byun, Ji Young Kim, Akechai Im-Aram, Jihoon Lee, Semi Lim, Ki Won Lee, Jeong Yong Suh, Hyong Joo Lee, Benjamin K. Tsang

Division of Life Sciences

Research output: Contribution to journal › Article › peer-review

77 Citations (Scopus)

Abstract

Background: Chemotherapeutic sensitivity in ovarian cancer is dependent on effective apoptosis signaling. Results: Piceatannol enhances cisplatin sensitivity by modulating p53, XIAP (X-linked inhibitor of apoptosis protein), and mitochondrial fission in vitro and in vivo. Conclusion: Piceatannol is a potent enhancer of cisplatin-induced apoptosis. Significance: Piceatannol exhibits potential for clinical development for the treatment of ovarian cancer.

Original language	English
Pages (from-to)	23740-23750
Number of pages	11
Journal	Journal of Biological Chemistry
Volume	288
Issue number	33
DOIs	https://doi.org/10.1074/jbc.M113.487686
Publication status	Published - 2013 Aug 16

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1074/jbc.M113.487686

Cite this

Farrand, L., Byun, S., Kim, J. Y., Im-Aram, A., Lee, J., Lim, S., Lee, K. W., Suh, J. Y., Lee, H. J., & Tsang, B. K. (2013). Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission. Journal of Biological Chemistry, 288(33), 23740-23750. https://doi.org/10.1074/jbc.M113.487686

@article{062e7489628346eb9d102a1f1bdc5061,

title = "Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission",

abstract = "Background: Chemotherapeutic sensitivity in ovarian cancer is dependent on effective apoptosis signaling. Results: Piceatannol enhances cisplatin sensitivity by modulating p53, XIAP (X-linked inhibitor of apoptosis protein), and mitochondrial fission in vitro and in vivo. Conclusion: Piceatannol is a potent enhancer of cisplatin-induced apoptosis. Significance: Piceatannol exhibits potential for clinical development for the treatment of ovarian cancer.",

author = "Lee Farrand and Sanguine Byun and Kim, {Ji Young} and Akechai Im-Aram and Jihoon Lee and Semi Lim and Lee, {Ki Won} and Suh, {Jeong Yong} and Lee, {Hyong Joo} and Tsang, {Benjamin K.}",

year = "2013",

month = aug,

day = "16",

doi = "10.1074/jbc.M113.487686",

language = "English",

volume = "288",

pages = "23740--23750",

journal = "Journal of Biological Chemistry",

issn = "0021-9258",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "33",

}

Farrand, L, Byun, S, Kim, JY, Im-Aram, A, Lee, J, Lim, S, Lee, KW, Suh, JY, Lee, HJ & Tsang, BK 2013, 'Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission', Journal of Biological Chemistry, vol. 288, no. 33, pp. 23740-23750. https://doi.org/10.1074/jbc.M113.487686

TY - JOUR

T1 - Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission

AU - Farrand, Lee

AU - Byun, Sanguine

AU - Kim, Ji Young

AU - Im-Aram, Akechai

AU - Lee, Jihoon

AU - Lim, Semi

AU - Lee, Ki Won

AU - Suh, Jeong Yong

AU - Lee, Hyong Joo

AU - Tsang, Benjamin K.

PY - 2013/8/16

Y1 - 2013/8/16

N2 - Background: Chemotherapeutic sensitivity in ovarian cancer is dependent on effective apoptosis signaling. Results: Piceatannol enhances cisplatin sensitivity by modulating p53, XIAP (X-linked inhibitor of apoptosis protein), and mitochondrial fission in vitro and in vivo. Conclusion: Piceatannol is a potent enhancer of cisplatin-induced apoptosis. Significance: Piceatannol exhibits potential for clinical development for the treatment of ovarian cancer.

AB - Background: Chemotherapeutic sensitivity in ovarian cancer is dependent on effective apoptosis signaling. Results: Piceatannol enhances cisplatin sensitivity by modulating p53, XIAP (X-linked inhibitor of apoptosis protein), and mitochondrial fission in vitro and in vivo. Conclusion: Piceatannol is a potent enhancer of cisplatin-induced apoptosis. Significance: Piceatannol exhibits potential for clinical development for the treatment of ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=84882440944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882440944&partnerID=8YFLogxK

U2 - 10.1074/jbc.M113.487686

DO - 10.1074/jbc.M113.487686

M3 - Article

C2 - 23833193

AN - SCOPUS:84882440944

VL - 288

SP - 23740

EP - 23750

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 33

ER -

Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this